Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies.
about
Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Long-term safety of long-actin ...... bo-controlled phase 3 studies.
@en
Long-term safety of long-actin ...... bo-controlled phase 3 studies.
@nl
type
label
Long-term safety of long-actin ...... bo-controlled phase 3 studies.
@en
Long-term safety of long-actin ...... bo-controlled phase 3 studies.
@nl
prefLabel
Long-term safety of long-actin ...... bo-controlled phase 3 studies.
@en
Long-term safety of long-actin ...... bo-controlled phase 3 studies.
@nl
P2093
P2860
P50
P1433
P1476
Long-term safety of long-actin ...... bo-controlled phase 3 studies.
@en
P2093
Anastasia Lesogor
Geoffrey Holder
Johannes Eisinger
Michaela Paul
Pierre Jordaan
Severine Sarp
P2860
P2888
P356
10.1007/S12020-017-1448-5
P577
2017-11-07T00:00:00Z